Tyloxapol: Difference between revisions
Content deleted Content added
m Dating maintenance tags: {{Fact}} |
template:Pmid -> template:Cite pmid per Wikipedia:Redirects for discussion/Log/2014 July 2#Template:Pmid, replaced: {{pmid → {{cite pmid (3) using AWB |
||
| Line 49: | Line 49: | ||
}} |
}} |
||
'''Tyloxapol''' is a nonionic liquid [[polymer]] of the alkyl aryl polyether alcohol type. It is used as a [[surfactant]] to aid [[liquefaction]] and removal of mucopurulent{{fact|date=December 2013}} (containing [[mucus]] and [[pus]]) bronchopulmonary secretions,<ref>{{pmid|8151722}}</ref><ref>{{pmid|1555424}}</ref> administered by inhalation through a [[nebulizer]]<ref>Drugs.com: [http://www.drugs.com/dict/tyloxapol.html Tyloxapol definition]</ref> or with a stream of oxygen. |
'''Tyloxapol''' is a nonionic liquid [[polymer]] of the alkyl aryl polyether alcohol type. It is used as a [[surfactant]] to aid [[liquefaction]] and removal of mucopurulent{{fact|date=December 2013}} (containing [[mucus]] and [[pus]]) bronchopulmonary secretions,<ref>{{cite pmid|8151722}}</ref><ref>{{cite pmid|1555424}}</ref> administered by inhalation through a [[nebulizer]]<ref>Drugs.com: [http://www.drugs.com/dict/tyloxapol.html Tyloxapol definition]</ref> or with a stream of oxygen. |
||
With [[intraperitoneal injection]], tyloxapol also blocks plasma lipolytic activity, and thus the breakdown of [[triglyceride]]-rich [[lipoprotein]]s. This mechanism is used to induce experimental [[hyperlipidemia]] in animals.<ref>{{pmid|12231215}}</ref> |
With [[intraperitoneal injection]], tyloxapol also blocks plasma lipolytic activity, and thus the breakdown of [[triglyceride]]-rich [[lipoprotein]]s. This mechanism is used to induce experimental [[hyperlipidemia]] in animals.<ref>{{cite pmid|12231215}}</ref> |
||
==References== |
==References== |
||
Revision as of 22:23, 12 July 2014
 | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.209.660 |
| Chemical and physical data | |
| Formula | (C15H21O(C2H4O)m)n |
| Molar mass | variable |
  (what is this?) (verify) | |
Tyloxapol is a nonionic liquid polymer of the alkyl aryl polyether alcohol type. It is used as a surfactant to aid liquefaction and removal of mucopurulent[citation needed] (containing mucus and pus) bronchopulmonary secretions,[1][2] administered by inhalation through a nebulizer[3] or with a stream of oxygen.
With intraperitoneal injection, tyloxapol also blocks plasma lipolytic activity, and thus the breakdown of triglyceride-rich lipoproteins. This mechanism is used to induce experimental hyperlipidemia in animals.[4]
References
- ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 8151722, please use {{cite journal}} with
|pmid=8151722instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 1555424, please use {{cite journal}} with
|pmid=1555424instead. - ^ Drugs.com: Tyloxapol definition
- ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 12231215, please use {{cite journal}} with
|pmid=12231215instead.
 | This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it. |